| |
| |
|
| Insider
Information: |
Wahl Bryan |
| Relationship: |
General Counsel |
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
40,951 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
40,951 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tarsus Pharmaceuticals, Inc. |
TARS |
General Counsel |
2024-03-18 |
40,951 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TARS |
Tarsus Pharmaceuticals, I... |
General Counsel |
• – – |
2024-03-18 |
4 |
S |
$30.60 |
$135,742 |
D/D |
(4,436) |
40,951 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
General Counsel |
• – – |
2024-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,038 |
45,387 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
General Counsel |
• – – |
2023-11-30 |
4 |
S |
$16.31 |
$136,286 |
D/D |
(8,356) |
31,966 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
General Counsel |
• – – |
2023-11-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,920 |
40,322 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
General Counsel |
• – – |
2023-03-23 |
4 |
S |
$12.15 |
$4,508 |
D/D |
(371) |
16,402 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
General Counsel |
• – – |
2023-03-22 |
4 |
S |
$12.64 |
$4,512 |
D/D |
(357) |
16,773 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
General Counsel |
• – – |
2023-03-21 |
4 |
S |
$12.89 |
$4,512 |
D/D |
(350) |
17,130 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
General Counsel |
• – – |
2023-03-20 |
4 |
S |
$12.61 |
$4,502 |
D/D |
(357) |
17,480 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
General Counsel |
• – – |
2023-03-17 |
4 |
S |
$13.28 |
$4,502 |
D/D |
(339) |
17,837 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
General Counsel |
• – – |
2023-03-16 |
4 |
S |
$13.43 |
$4,526 |
D/D |
(337) |
18,176 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
General Counsel |
• – – |
2023-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,790 |
18,513 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
General Counsel |
• – – |
2022-12-02 |
4 |
S |
$16.90 |
$19,503 |
D/D |
(1,154) |
13,723 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
General Counsel |
• – – |
2022-12-01 |
4 |
S |
$16.75 |
$19,497 |
D/D |
(1,164) |
14,877 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
General Counsel |
• – – |
2022-11-30 |
4 |
S |
$16.50 |
$19,520 |
D/D |
(1,183) |
16,041 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
General Counsel |
• – – |
2022-11-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,251 |
17,224 |
0 |
- |
|
| TARS |
Tarsus Pharmaceuticals, I... |
General CounselOfficer |
• – – |
2021-01-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
